GWAAIS 2018 1st Quarterly Meeting

Bethesda, MD US
April 11, 2018

Formal presentation on the gut microbiome and how it effects our overall health in particular our immune system as it relates to atopy.

Accreditation  

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Greater Washington Allergy, Asthma & Immunology Society.  The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
This activity is not supported by independent medical education grants.

Target Audience

Practicing allergists, physicians and allied health professionals.

Learning Objectives

Upon completion of this activity participants should be able to:

1) describe the role of gut bacteria in atopy

2) recognize the role of prebiotics and probiotics in treating atopy

3) identify which tests to order to evaluate the microbiome in atopic patients

Additional information
Disclosure: 

Disclosure Policy and Disclosures
As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all educational planners, presenters, instructors, moderators, authors, reviewers, and other individuals in a position to control or influence the content of an activity must disclose all relevant financial relationships with any commercial interest that have occurred within the past 12 months. All identified conflicts of interest must be resolved and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure be provided to the learners prior to the start of the activity. Individuals with no relevant financial relationships must also inform the learners that no relevant financial relationships exist. Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials. Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI.

All identified conflicts of interest have been resolved.

The following have no relevant financial relationships to disclose:

Robynne Chutkan, MD - Speaker

Sally Bailey, MD – Program Chair

Susan McMath – Staff Administrator

Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
04/11/2018
Course expires: 
04/11/2020
Event starts: 
04/11/2018 - 7:00pm
Event ends: 
04/11/2018 - 8:45pm
Cost:
$0.00
Rating: 
0
Bethesda Marriott
5151 Pooks Hill Road
Bethesda, MD 20814
United States
+1 (301) 897-9400

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance

Accreditation Period

Course opens: 
04/11/2018
Course expires: 
04/11/2020

Price

Cost:
$0.00
Please login or create an account to take this course.